Vitalhub Corp. (TSE:VHI - Get Free Report) has been given an average recommendation of "Buy" by the seven brokerages that are presently covering the company, MarketBeat reports. Six analysts have rated the stock with a buy recommendation and one has given a strong buy recommendation to the company. The average 12-month price target among brokerages that have updated their coverage on the stock in the last year is C$13.25.
A number of analysts have weighed in on the company. Scotiabank boosted their price target on Vitalhub from C$14.00 to C$14.50 and gave the stock an "outperform" rating in a research report on Friday, June 20th. National Bank Financial raised Vitalhub to a "strong-buy" rating in a research report on Monday, June 9th. National Bankshares set a C$14.00 price target on Vitalhub and gave the stock an "outperform" rating in a research report on Tuesday, June 10th. Finally, Raymond James Financial boosted their price target on Vitalhub from C$13.50 to C$14.00 and gave the stock an "outperform" rating in a research report on Friday, June 20th.
Get Our Latest Report on VHI
Insider Activity at Vitalhub
In other Vitalhub news, Director Francis Nelson Shen bought 25,000 shares of Vitalhub stock in a transaction dated Friday, May 16th. The shares were acquired at an average cost of C$10.23 per share, with a total value of C$255,750.00. 18.57% of the stock is owned by insiders.
Vitalhub Stock Down 1.7%
Shares of TSE:VHI traded down C$0.23 on Wednesday, reaching C$13.53. The company had a trading volume of 241,434 shares, compared to its average volume of 131,067. Vitalhub has a twelve month low of C$7.48 and a twelve month high of C$14.34. The stock has a 50-day moving average price of C$11.50 and a 200 day moving average price of C$10.80. The stock has a market capitalization of C$731.87 million, a P/E ratio of 220.06, a P/E/G ratio of 1.18 and a beta of 1.26.
Vitalhub Company Profile
(
Get Free ReportVitalhub Corp., together with its subsidiaries, provides technology solutions for health and human service providers in Canada, the United States, the United Kingdom, Australia, Western Asia, and internationally. Its solutions include electronic healthcare record, case management, care coordination and optimization, and patient flow, engagement, and operational visibility solutions.
Featured Articles

Before you consider Vitalhub, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Vitalhub wasn't on the list.
While Vitalhub currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.